Recurrent Adult Immunoblastic Large Cell Lymphoma Completed Phase 0 Trials for Cyclophosphamide (DB00531)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma) | Completed | 0 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01959477 | Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant | Treatment |